Therefore, we also defined the annual prevalence of NTM-positivity, which showed an increasing trend over the study period (5.7 % (11/192) in 2020, 10.2 % (20/197) in 2021 and 12.9 % (30/232) in 2022) ( Table 2 ).
← all excerpts
Epidemiology, microbiology and clinical impacts of non-tuberculous mycobacteria in adult patients with cystic fibrosis.
1
—
—